Synergistic inhibition of breast cancer cell lines with a dual inhibitor of EGFR-HER-2/neu and a Bcl-2 inhibitor. - Wikidata - wikimedia - TriplyDB

Synergistic inhibition of breast cancer cell lines with a dual inhibitor of EGFR-HER-2/neu and a Bcl-2 inhibitor.

Synergistic inhibition of breast cancer cell lines with a dual inhibitor of EGFR-HER-2/neu and a Bcl-2 inhibitor.

http://www.wikidata.org/entity/Q40186990

about

Coptis extracts enhance the anticancer effect of estrogen receptor antagonists on human breast cancer cells Ramentaceone, a Naphthoquinone Derived from Drosera sp., Induces Apoptosis by Suppressing PI3K/Akt Signaling in Breast Cancer Cells Chemoprevention of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamster cheek pouch by topical application of a dual inhibitor of epidermal growth factor receptor (EGFR) and ErbB2 tyrosine kinases Estrogen regulation of anti-apoptotic Bcl-2 family member Mcl-1 expression in breast cancer cells RFX1-dependent activation of SHP-1 induces autophagy by a novel obatoclax derivative in hepatocellular carcinoma cells.VSV oncolysis in combination with the BCL-2 inhibitor obatoclax overcomes apoptosis resistance in chronic lymphocytic leukemia.Optimization of circulating biomarkers of obatoclax-induced cell death in patients with small cell lung cancer.Bcl-2 inhibitor and apigenin worked synergistically in human malignant neuroblastoma cell lines and increased apoptosis with activation of extrinsic and intrinsic pathways.Small molecule inhibitors of bcl-2 family proteins for pancreatic cancer therapy Epidermal growth factor regulates Mcl-1 expression through the MAPK-Elk-1 signalling pathway contributing to cell survival in breast cancer Targeting Bcl-2 in Herceptin-Resistant Breast Cancer Cell Lines.Upregulation of ER Signaling as an Adaptive Mechanism of Cell Survival in HER2-Positive Breast Tumors Treated with Anti-HER2 Therapy.EGFR and HER2 receptor kinase signaling mediate epithelial cell invasion by Candida albicans during oropharyngeal infection Inhibitors of the anti-apoptotic Bcl-2 proteins: a patent review.Lapatinib resistance in HCT116 cells is mediated by elevated MCL-1 expression and decreased BAK activation and not by ERBB receptor kinase mutation New developments in the treatment of HER2-positive breast cancer Bcl2 family proteins in carcinogenesis and the treatment of cancer.Cell death induction by the BH3 mimetic GX15-070 in thyroid carcinoma cells GW583340 and GW2974, human EGFR and HER-2 inhibitors, reverse ABCG2- and ABCB1-mediated drug resistance.BH3-only protein mimetic obatoclax sensitizes cholangiocarcinoma cells to Apo2L/TRAIL-induced apoptosis Anti-cancer drug discovery and development: Bcl-2 family small molecule inhibitors.

P2860

Q24594804-EC4E96A8-B7CF-443B-B4F0-90C1F4CA82DC Q28553060-585DD52C-36EC-4033-A1B4-3A27DCB3BAFC Q33302631-CED581E2-91B9-454E-9318-E338F20496B1 Q33817324-2FE8159F-AAE2-49BD-8355-51689CBB3AA4 Q34104089-14D04D29-AD10-4549-9334-9257DDC7CB2D Q34382986-8961BB21-C86D-499F-9867-C88CDFD72DBE Q34763661-C649E801-AEA1-4DED-958B-6810494DFBB1 Q35013095-315B3122-1B5C-480C-91D1-C650CD58BF9C Q35099238-8BBD0B3C-95DD-489B-A358-6ED0890427B8 Q35134513-78EC208D-56F1-46EA-996D-B55712DBB43A Q35599629-3664F716-5B10-4997-B9BB-5DB7A08E74B0 Q36021424-9B839C90-DFD7-41D6-9150-95F0EDD637BB Q36212929-7B387B6A-9141-433A-8F5E-0D9B56EF7D80 Q36541458-D3D625AE-4528-4219-BEC7-0B29826CB76A Q36952270-FEA5F8E1-7046-4C8A-B981-E8579F9E103D Q37016382-C5B3F860-8228-4E17-A646-B49F899C76EB Q37373448-5E896A10-F7FC-40C3-99BC-05C90EA7EF71 Q38850608-F6DC31B0-8008-4BB5-B962-FB87761090C1 Q39380536-47DD8094-B1A8-471D-AB34-F3F8D9C4B895 Q39947763-D9776E63-BA73-4646-9CEE-B584E1ADDC35 Q42061450-7241BA37-65F5-4DE2-929D-29D4033F0FDC

P2860

Synergistic inhibition of breast cancer cell lines with a dual inhibitor of EGFR-HER-2/neu and a Bcl-2 inhibitor.

http://www.wikidata.org/entity/Q40186990

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Synergistic inhibition of brea ...... R-2/neu and a Bcl-2 inhibitor.

@en

type

label

Synergistic inhibition of brea ...... R-2/neu and a Bcl-2 inhibitor.

@en

prefLabel

Synergistic inhibition of brea ...... R-2/neu and a Bcl-2 inhibitor.

@en

P1433

Q40186990-1B673CF7-2C9F-4655-B25E-C963004BFF3A

P1476

Q40186990-EEE7BBEF-F4C2-42FA-971E-40299E30D6CC

P2093

Q40186990-05F3B579-BFAC-4F75-9D17-B9D3CCFCE636

Q40186990-67EDB330-907B-4652-B14F-2D16465DAF00

Q40186990-7A59F89C-E0EC-4ABC-A7EA-C8266ED1D743

Q40186990-C13AFEF4-4F18-4977-90B5-EA8B160E93A8

Q40186990-EEDE4CEE-96D7-4512-AA2F-65774B75C595

Q40186990-F8D05378-38EE-44D0-B0CE-0BF0C1C653F8

P304

Q40186990-5F6E4D09-A411-4A40-8775-0985D2B2140B

P31

Q40186990-65AA6D7F-CA27-4EED-BD78-B5D7F4B693D7

P433

Q40186990-BFFDB388-F678-4D60-BAD8-B1F52F22C5FF

P478

Q40186990-148CB066-F583-4157-9CD2-64F0C8A955CC

P577

Q40186990-5EC2B6A1-EDA0-4768-98F2-363D7EEE72CB

P698

Q40186990-533C79E4-7BEE-4EC6-B8B6-85BA73893277

P1433

Oncology Reports

P1476

Synergistic inhibition of brea ...... R-2/neu and a Bcl-2 inhibitor.

@en

P2093

Allan Lipton

http://www.w3.org/2001/XMLSchema#string

Amy Witkoski

http://www.w3.org/2001/XMLSchema#string

Jean Viallet

http://www.w3.org/2001/XMLSchema#string

Lois M Witters

http://www.w3.org/2001/XMLSchema#string

Maricarmen D Planas-Silva

http://www.w3.org/2001/XMLSchema#string

Mark Berger

http://www.w3.org/2001/XMLSchema#string

P304

465-469

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2007-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17203189

http://www.w3.org/2001/XMLSchema#string